ODI Pharma AB (publ) (NGM: ODI)
Sweden
· Delayed Price · Currency is SEK 5.15
-0.15 (-2.83%)
At close: Sep 6, 2024
ODI Pharma AB Revenue
In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.45M SEK with 15,996.09% growth. ODI Pharma AB had revenue of 7.54M in the quarter ending June 30, 2024, with 27,460.17% growth.
Revenue
22.45M
Revenue Growth
+15,996.09%
P/S Ratio
3.49
Revenue / Employee
22.45M
Employees
1
Market Cap
78.38M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition